Executive Committee

Gracia Perez-Lirio
MD

Dr. Perez-Lirio is the medical director of Beth Israel Healthcare after hour clinic, staff physician, department of medicine, clinical instructor of Harvard Medical School, Faculty Lecturer, Tufts Medical School, she also serves on Medical Education Committee, Beth Israel Deaconess Needham and Ethics Committee Liaison, Beth Israel Medical Center Boston. She is executive committee member of ACMES and North American Journal of Medicine and Science.

Yi Zhang
MD, PhD, M.Sc

Dr. Zhang isStaff  Physician and Instructor of the Department Of Anesthesia, Critical Care and Pain Medicine at the Massachusetts General Hospital, Boston. Dr. Zhang was trained as a physician in Peking Union Medical College & Chinese Academy of Medical Sciences (PUMC & CAMS), Beijing, and Tongji Medical University, Wuhan, China. He then obtained his Ph.D. in Neuroscience from Johns Hopkins University School of Medicine and hisMaster of Science degree in Computer Science from Johns Hopkins University School of Engineering. Dr. Zhang’s current research focuses on critical care and pain medicine. His novel findings have led to publications in various major journals in the field. He is executive committee member of ACMES, meeting moderator and To Cure Autism Institute.

Martha Herbert
MD, PhD

Dr. Herbert is Assistant professor of neurology at Harvard Medical School and a pediatric neurologist at Massachusetts General Hospital, where she is the director of the TRANSCEND Research Program. She is an affiliate of the Harvard-MGH-MIT-HST Martinos Center for Biomedical Imaging. Dr. Herbert earned her medical degree at the Columbia University College of Physicians and Surgeons. Prior to her medical training she obtained a doctoral degree at the University of California, Santa Cruz, studying evolution and development of learning processes in biology and culture in the History of Consciousness program, and then did postdoctoral work in the philosophy and history of science. She trained in pediatrics at Cornell University Medical Center and in neurology and child neurology at Massachusetts General Hospital, where she has remained. She received the first Cure Autism Now Innovator Award and is on the Scientific Advisory Committee of Autism Speaks. She is active collaborator, speaker and executive member of ACMES and to cure autism institute.

William Stone
PhD, ABPP-CN

William Stone, PhD, ABPP-CN, Dr. Stone is Director of Neuropsychology Training and Clinical Services, Massachusetts Mental Health Center (MMHC); Director of Neuropsychology Fellowship Program at MMHC and Beth Israel Deaconess Medical Center (BIDMC); Assistant Professor of Psychology, Harvard Medical School, staff clinical psychologist of department of psychiatry, BIDMC. His research is focused on identifying cognitive, clinical and biological risk factors for the development of psychiatric illness. These efforts emphasize attempts to identify liability syndromes for schizophrenia and related disorders. They also aim to develop interventions that will alter or prevent the trajectory to psychosis and other manifestations of major mental illness. He is executive committee member of ACMES and editor of North American Journal of Medicine and Science.

Bailin Wu
PhD, ABPP-CN

Dr. Wu is a Diplomate of the American Board of Medical Genetics and an elected Fellow of the American College of Medical Genetics. Dr. Wu is the past President of  the Association of Chinese Geneticists in America (2006-07) and has been playing an active leadership role in the community of overseas Chinese Geneticists, in which he has helped to organize various scientific events between the U.S. and great China region, including the historic conference “Health Care, East and West, Moving into the 21st Century” (co-hosted by Harvard Medical School, MIT and Chinese Medical Association), Beijing’s 2004 International Conference on Medical Genetics, Shanghai’s 2005 ACGA-Fudan International Symposium on Genomic Medicine, Hong Kong’s 2008 ACGA-HKSMG International Conference on Genetic and Genomic Medicine, and Taiwan’s 2009 International Conference on Genomic Medicine.  Dr. Wu's research contributions and recent publications by peer reviewed journals include N Engl J Med, Nature, Cell, AJHG, AJMG, J Med Gen, ClinChem, Clin Gen, Genet Med, JGG, J Mole Diag, Neuropsychiatr Genet, Pediatrics, PLOS One. He is executive committee member of ACMES, specialty editor of North American Journal of Medicine and Health and co-editor-in-chief for special genetic issues of NAJMS.

David Lee
PhD

Dr. Lee is an associate professor at Harvard Medical School and the Director of the Bioorganic and Natural Products Laboratory at McLean Hospital. He completed his Ph.D. degree in Natural Products Chemistry at Columbia University. Dr. Lee has worked on numerous projects in drug discovery and development related to traditional Chinese medicine. He and his team isolated a potent topoisomerase I inhibitor (NPI-BC-4) from Boswelliacaterii, a traditional medicine used in the treatment of inflammatory diseases in India and China without overt toxicity. A preliminary clinical trial of NPI-BC-4 in Germany showed excellent results in patients with brain tumors. Because of its specific activity against CNS (SP-295) and prostate cancer cell lines (DU-145 and PC-3), NPI-BC-4 is also being developed as a potential non-hormonal therapy for advanced prostate cancer and for early intervention, including benign prostate hyperplasia. Dr. Lee has contributed significantly to the development of alternative therapies for substances abuse. He is the principal investigator on a program project grant funded by the National Institutes of Health entitled “Alternative Therapies for Alcohol and Drug Abuse.” Under this program, several isoflavone glycosides have been identified and assessed in animal models of alcoholism. Because of their favorable toxicity profile in comparison with naltrexone, an FDA approved drug, and their suppression of alcohol drinking in alcohol preferring rats, these isoflavone glycosides stand a good chance of development for the treatment of alcoholism. Dr. Lee is also serving as Co-PI on the development of the herbal remedy (HLXL) for osteoarthritis. Dr. Lee and his colleagues at McLean Hospital are also looking into natural remedies for depression, insomnia, and Alzheimer’s disease. Dr. Lee received an institutional development award in 1985. He has published 100 papers and holds 15 U.S. and international patents. He is executive committee member of ACMES and associate editor of North American Journal of Medicine and Health.

Le Min
MD

Department of Endocrinology, Diabetes, and Hypertension, Brigham & Woman’s Hospital, Harvard Medical School. Dr. Le Min is working as an endocrinologist at Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women’s Hospital and an instructor of Medicine at Harvard Medical School, Boston. He received his MD degree from Chongqing Medical University at Chongqing, China and a Ph.D. degree from National University of Singapore. He had his medical residency training at Mount Sinai School of Medicine (North General) Program and fellowship training at Brigham and Women’s Hospital. He had postdoctoral training at University of Iowa and Stony Brook University as well. His current research interest is to understand the role of kisspeptin receptor on reproductive regulation and puberty onset. He is executive committee member of ACMES,speaker and moderator, editor of North American Journal of Medicine and Health.

Chieh Li
Ed.D

Chieh Li is an associate professor and director of clinical training of the M.S. and Ph.D. School Psychology Programs in the Department of Counseling and Applied Educational Psychology  at Northeastern University. She teaches masters and doctoral courses on multicultural counseling and assessment and does research on cross-cultural psychology. As a bilingual (Chinese and English) psychologist, she also writes on bilingual and bicultural issues in the practice of counseling and school psychology, including assessment of culturally and linguistically diverse students. She has also been exploring the impact of traditional Chinese culture and meditation on health and creativity. Dr. Li is the past chair of the Bouvé College Diversity Committee, the national Council of Directors of School Psychology Programs (CDSPP) and the CDSPP Practicum Taskforce. She is executive committee member of ACMES and to cure autism institute, and editor of North American Journal of Medicine and Health.

Pages